Search bioRxivSearch

bioRxiv · 10.1101/260075

Automatic Cell Segmentation by Adaptive Thresholding (ACSAT) for large scale calcium imaging datasets

Abstract

Advances in calcium imaging have made it possible to record from an increasingly larger number of neurons simultaneously. Neuroscientists can now routinely image hundreds to thousands of individual neurons. With the continued neurotechnology development effort, it is expected that millions of neurons could soon be simultaneously measured. An emerging technical challenge that parallels the advancement in imaging such a large number of individual neurons is the processing of correspondingly large datasets, an important step of which is the identification of individual neurons. Traditional methods rely mainly on manual or semi-manual inspection, which cannot be scaled to processing large datasets. To address this challenge, we have developed an automated cell segmentation method, which is referred to as Automated Cell Segmentation by Adaptive Thresholding (ACSAT). ACSAT includes an iterative procedure that automatically calculates global and local threshold values during each iteration based on image pixel intensities. As such, the algorithm is capable of handling morphological variations and dynamic changes in fluorescence intensities in different calcium imaging datasets. In addition, ACSAT computes adaptive threshold values based on a time-collapsed image that is representative of the image sequence, and thus ACSAT provides segmentation results at a fast speed. We tested the algorithm on wide-field calcium imaging datasets in the brain regions of hippocampus and striatum in mice. ACSAT achieved precision and recall rates of approximately 80% when compared to individual neurons that are verified by human inspection. Additionally, ACSAT successfully detected low-intensity neurons that were initially undetected by humans.\n\nSignificanceACSAT automatically segments cells in large scale wide-field calcium imaging datasets. It is based on adaptive thresholding at both global and local levels, implemented in an iterative process to identify individual neurons in a time-collapsed image from an image sequence. It is therefore capable of handling variation in cell morphology and dynamic changes between different calcium imaging datasets at a fast speed. Based on tests performed on two datasets from mouse hippocampus and striatum, ACSAT performed comparable to human referees and was even able to detect low-intensity neurons that were initially undetected by human referees.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Shen, S. P., Tseng, H.-a., Hansen, K. R., Wu, R., Gritton, H., Si, J., Han, X.. 2018-02-05. Automatic Cell Segmentation by Adaptive Thresholding (ACSAT) for large scale calcium imaging datasets. https://doi.org/10.1101/260075

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience